GGrantIndex
Sort

50,496 grants matching lung cancer

Exploring the Function of MHC-II/Lag3 Axis in Brain Metastasis to Develop Novel Therapeutic Strategies

$499,828
Dihua Yu · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA

High-Precision Lung Radiotherapy by Intra-treatment Dynamic Cone-beam CT imaging and Dosimetry-guided Plan Adaptation

$499,826
You Zhang · Ut Southwestern Medical Center · R01 · FY2025 · EB

Epigenetic and microenvironmental regulation of dormant disseminated cancer

$499,826
Julio A Aguirre-Ghiso · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA

Cancer Related Health Disparities Education and Career Development Program

$499,818
Jean Forster · University Of Minnesota · R25 · FY2014 · CA

Comparative effectiveness research using NCCN data

$499,795
Jane C. Weeks · Dana-Farber Cancer Inst · RC1 · FY2009 · CA

Implementing Systemic Interventions to Close the Discovery-Delivery Gap

$499,788
Bryan J. Weiner · Univ Of North Carolina Chapel Hill · R01 · FY2009 · CA

ALPHA 1 AD CARRIERS AND LUNG CANCER RISK

$499,786
Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2001 · CA

Signal Transduction Pathways that Promote Survival of Lung Cancer Cells

$499,781
Phillip A. Dennis · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA

Development of Akt Inhibitors

$499,781
Phillip A. Dennis · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

The Women's Health Study: Addition of New Data to Maximize its Research Impact

$499,778
Julie E Buring · Brigham And Women'S Hospital · RC1 · FY2009 · HL

A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer

$499,770
Kristine L Kwekkeboom · University Of Wisconsin-Madison · R01 · FY2016 · NR

OHSU Knight Cancer Institute

$499,758
Brian J Druker · Oregon Health & Science University · P30 · FY2020 · CA

Brief Behavioral Intervention for Dyspnea in Patients with Advanced Lung Cancer

$499,749
Joseph Andrew Greer · Massachusetts General Hospital · R01 · FY2018 · NR

Brief Behavioral Intervention for Dyspnea in Patients with Advanced Lung Cancer

$499,749
Joseph Andrew Greer · Massachusetts General Hospital · R01 · FY2019 · NR

Brief Behavioral Intervention for Dyspnea in Patients with Advanced Lung Cancer

$499,749
Joseph Andrew Greer · Massachusetts General Hospital · R01 · FY2021 · NR

Brief Behavioral Intervention for Dyspnea in Patients with Advanced Lung Cancer

$499,749
Joseph Andrew Greer · Massachusetts General Hospital · R01 · FY2020 · NR

INHERITED AND SOMATIC ALTERATIONS OF THE TGF-B LIGAND AND RECEPTOR COMPLEX IN C..

$499,676
Christopher M Weghorst · Ohio State University · P50 · FY2016 · CA

Statistical methods for genomic analysis of heterogeneous tumors

$499,663
Wenyi Wang · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Early Functional Genetic and Epigenetic Changes in Human Lung Carcinogenesis

$499,629
Simon Daniel Spivack · Albert Einstein College Of Medicine · RC1 · FY2009 · CA

Molecular biomarkers of airway and lung linking COPD and Lung Cancer

$499,578
Avrum E Spira · Boston University Medical Campus · R01 · FY2014 · CA

Project 3

$499,545
Dimitrios P Kontoyiannis · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · P01 · FY2025 · AI

A Tool to Improve Evaluation of Patient Navigation Services in Underserved Populations

$499,535
Linda Burhansstipanov · Native American Cancer Initiatives, Inc. · R44 · FY2018 · MD

LACE-Bio-II: Identification, validation and implementation of prognostic and/or p

$499,487
Lesley Katie Seymour · Queen'S University At Kingston · R01 · FY2015 · CA

Liquid biopsy of solitary pulmonary nodule with extracellular vesicles

$499,472
Yuan Wan · State University Of Ny,Binghamton · R37 · FY2021 · CA

IGF::OT::IGF Recipient Epidemiology and Donor Evaluation Study III (REDS-III) ¿ Phase 3 - Domestic Site - ITXM

$499,439
Lynne Trzyna · Institute For Transfusion Medicine · N01 · FY2017 · HL